Beschreibung

The advances in oncology of the past thirty years have been spectacular and are closely linked to the biomedical revolution in medicine. Roche – today the largest biopharmaceuticals company in the world –  has been at the forefront of these developments. The book starts with the origins of cancer treatment and the company’s early involvement in making cancer a more manageable disease. The development of molecular biology as a pharmaceutical tool is described in detail including Roche’s trailblazing investments in the Roche Institute for Molecular Biology, the Basel Institute for Immunology and Genentech.